Journal profile · PERIPHERAL VASCULAR DISEASE
Integrated Blood Pressure Control
ISSN 1178-7104 · Dove Medical Press · United Kingdom
Integrated Blood Pressure Control: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 2,320; review about 16 weeks (community reports); 4 articles a year; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Integrated Blood Pressure Control is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Sodium Intake and Health and Hormonal Regulation and Hypertension, together about 52.4% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Steven Atlas, MD Integrated Blood Pressure Control is an international, peer-reviewed, open-access journal focusing on the integrated approach to managing hypertension and risk reduction. Treating the patient and comorbidities together with diet and lifestyle modification and optimizing healthcare resources through a multidisciplinary team approach constitute key features of the journal. Epidemiology, screening, diagnosis, and monitoring will also be covered. Specific topics also include: Hypertension and co-existing disease Pathophysiology Risk factor modification Blood pressure monitoring programs and specific devices Treatment including pharmacological and non-pharmacological Complications of hypertension and treatment Safety Quality of Life Patient satisfaction and preference Health economic evaluations Health Policy The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports. The main focus of the journal will be to publish research and clinical results in humans but preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies and interventions. Integrated Blood Pressure Control will no longer consider meta-analyses for publication.
From the journal's Aims & Scope
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Editor-in-chief Steven AtlasPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine32.4%
- Sodium Intake and HealthNursing10.6%
- Hormonal Regulation and HypertensionMedicine9.4%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine4.7%
- Cardiovascular Health and Disease PreventionMedicine4.1%
- Heart Rate Variability and Autonomic ControlMedicine3.8%
- Renin-Angiotensin System StudiesMedicine3.2%
- Pregnancy and preeclampsia studiesMedicine2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
Early warning / risk: Marked as ceased in ESCI on 16 February 2026. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 6.4LetPub ·
- SJR 2026-06
- 0.57LetPub ·
- SNIP 2026-06
- 1.34LetPub ·
- h-index
- 36OpenAlex ·
- i10-index
- 101OpenAlex ·
- 2-year mean citedness
- 4.56OpenAlex ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 4LetPub ·
Articles by year OpenAlex count · 167 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2024 | 9 | 9 | 41 |
| 2023 | 11 | 11 | 98 |
| 2022 | 10 | 10 | 147 |
| 2021 | 19 | 19 | 215 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 2 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1178-7104
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Integrated Blood Pressure Control
What CAS zone is Integrated Blood Pressure Control in?
In the 2025 upgraded edition of the CAS Journal Ranking, Integrated Blood Pressure Control is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Integrated Blood Pressure Control?
Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Integrated Blood Pressure Control?
According to LetPub and DOAJ records, Integrated Blood Pressure Control is indexed in Scopus.
Is Integrated Blood Pressure Control open access, and what is the APC?
Integrated Blood Pressure Control is a fully open-access journal. APC about USD 2,320.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .